Is PZRXQ or PM a better dividend investment in 2026?

PZRXQ currently yields 2000000.00% with a 5% 5-year dividend growth rate. PM yields 3.48% with 2.8% growth. The better choice depends on your goal: PZRXQ offers higher current income.

What is the dividend yield difference between PZRXQ and PM?

PZRXQ has a forward dividend yield of 2000000.00% ($2.00/share annually). PM yields 3.48% ($5.76/share annually). The yield gap is 1999996.52 percentage points.

Home › Compare › PZRXQ vs PM

PZRXQ vs PM: Dividend Comparison 2026

PZRXQ yields 2000000.00% · PM yields 3.48%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PZRXQ wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PZRXQ

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full PZRXQ calculator →

Philip Morris International

● Live price

3.48%

Share price

$165.34

Annual div

$5.76

5Y div CAGR

17.2%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.6K

Annual income

$2,492.02

Full PM calculator →

Portfolio growth — PZRXQ vs PM

📍 PZRXQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PZRXQ	PM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PZRXQ + PM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PZRXQ pays

PM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PZRXQ

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

Annual income on $10K today (after 15% tax)

$296.12/yr

After 10yr DRIP, annual income (after tax)

$2,118.22/yr

At 15% tax rate, PZRXQ beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PZRXQ + PM for your $10,000?

PZRXQ: 50%PM: 50%

100% PM50/50100% PZRXQ

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

PZRXQ

No analyst data

Altman Z

-25.0

Piotroski

2/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$194.30

+17.5% upside vs current

Range: $180.00 — $205.00

Altman Z

4.0

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PZRXQ buys

PM buys

No recent congressional trades found for PZRXQ or PM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPZRXQPM

Forward yield	2000000.00% ✓	3.48%
Annual dividend / share	$2.00	$5.76 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	17.2% ✓
Portfolio after 10y	$4.879226400974806e+39M	$49.6K ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$2,492.02
Total dividends collected	$4.879195005460081e+39M	$11.7K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: PZRXQ vs PM ($10,000, DRIP)

Year	PZRXQ Portfolio	PZRXQ Income/yr	PM Portfolio	PM Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$11,648	$408.29	+$200.00M → PZRXQ
2	$3,738,731,768,458	$3,738,517,757,009.35	$13,589	$495.90	+$3738731.75M → PZRXQ
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$15,877	$603.21	+$65315062866.91M → PZRXQ
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$18,580	$734.88	+$1066400830062625.00M → PZRXQ
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$21,781	$896.75	+$16272182796453826560.00M → PZRXQ
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$25,578	$1,096.12	+$2.3205424011366188e+23M → PZRXQ
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$30,092	$1,342.17	+$3.0927990661046884e+27M → PZRXQ
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$35,470	$1,646.46	+$3.8524105697352695e+31M → PZRXQ
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$41,892	$2,023.58	+$4.484688260147987e+35M → PZRXQ
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$49,578	$2,492.02	+$4.879226400974806e+39M → PZRXQ

PZRXQ vs PM: Complete Analysis 2026

PZRXQ — Stock

PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. The company was incorporated in 2006 and is headquartered in Seattle, Washington.

Full PZRXQ Calculator →

PM — Consumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →

📬

Get this PZRXQ vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PZRXQ vs SCHD PZRXQ vs JEPI PZRXQ vs O PZRXQ vs KO PZRXQ vs MAIN PZRXQ vs MO PZRXQ vs BTI PZRXQ vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.